IsoPlexis Corporation (ISO) IPO Opens Modestly Lower
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- Wall Street rises on Iran war peace deal hopes, SpaceX's historic debut
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Super Micro Computer establishes $1.25 billion stock sale agreement
IsoPlexis Announces Pricing of Initial Public Offering
October 7, 2021 6:13 PM EDTBRANFORD, Conn., Oct. 7, 2021 /PRNewswire/ --Â IsoPlexis Corporation ("IsoPlexis"), a leader in functional single-cell proteomics, today announced the pricing of its initial public offering of 8,333,000Â shares of common stock at a public offering price of $15.00 per share. All of the shares of common stock are being offered by IsoPlexis. The gross proceeds from the offering, before deducting underwriting discounts and commissions and other offering expenses payable by IsoPlexis, are expected to be $125.0 million, excluding any exercise of the underwriters' option to purchase additional shares. IsoPlexis' common stock is expected to begin trading on The Nasdaq Global Select Market... More
